Chronic Obstructive Pulmonary Disease, COPD
Conditions
Interventions
Observation Group:none
Sponsors
Peking University First Hospital
Eligibility
Sex/Gender
All
Age
40 Years to 80 Years
Inclusion criteria
Inclusion criteria: 1. Age range from 40 to 80 years old; 2. Stable chronic obstructive pulmonary disease patients, with diagnostic criteria in accordance with the guidelines for the diagnosis and treatment of chronic obstructive pulmonary disease (revised in 2023); 3. Patients with chronic obstructive pulmonary disease who have experienced >= 2 moderate acute exacerbations (requiring systemic use of antibiotics or hormones) or >= 1 severe acute exacerbation (leading to hospitalization) in the past year, or >= 1 moderate or severe acute exacerbation in the past year; 4. Patients who are proficient in using smartphones and mobile apps themselves or with the assistance of family members; 5. The subjects voluntarily participated in the study and signed an informed consent form.
Exclusion criteria
Exclusion criteria: 1. Other chronic respiratory diseases or medical histories that cause decreased lung function, such as bronchial asthma, active lung cancer, active tuberculosis, bronchiectasis, severe thoracic or spinal deformities, diffuse lung diseases (interstitial pneumonia, occupational lung disease, sarcoidosis, etc.), and postoperative lobectomy or unilateral pneumonectomy; 2. Other serious underlying diseases of the system, including severe mental disorders, intellectual disabilities, neurological disorders (leading to limb mobility disorders, dementia, aphasia), active malignant tumors, chronic heart failure (NYHA>Level 3), chronic renal insufficiency requiring maintenance blood purification treatment, liver dysfunction, severe active autoimmune diseases, or long-term use of hormones and/or immunosuppressants, targeted biological therapy Unstable angina pectoris, uncontrolled hyperthyroidism or severe arrhythmia, acute phase or exacerbation of the aforementioned diseases, etc; 3. Those who require long-term non-invasive home ventilation due to respiratory failure; 4. Skin and soft tissue lesions, damages, or abnormal blood supply (vascular occlusion or thrombosis, trauma) in both upper limbs, which affect the wearing or measurement of the bracelet; 5. Those who fail to use the device/application correctly during the screening period, or fail to record or evaluate as required; 6. Those who are unable to wear a bracelet for a long time according to research requirements due to various reasons; 7. Pregnant women; 8. Other researchers believe that it is not suitable for enrollment.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Number and severity of acute exacerbations;Physiological indicators recorded by wearable devices; | — |
Countries
China
Contacts
Public ContactChi Chunhua
Peking University First Hospital
Outcome results
None listed